5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane

C90H87BrN16O7 — CID 159482660

IUPAC5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane
SMILESC.CC1=CC=C(C2=C(C(N)=O)C(N)=NC2)C1.Cc1cc(-c2cnc3c(c2)CCC3)c(C)n1-c1cccc(O)c1.Cc1cc(-c2cnc3ccccc3n2)c(C)n1-c1ccccc1.Cc1ccc(C(=O)Nc2cc(-c3cc(C)n(-c4ccc(Br)cc4)c3C)[nH]n2)cc1.NC(=O)c1c(N)noc1-c1ccc(-c2ccccc2)[nH]1.O=C=O
InChIInChI=1S/C23H21BrN4O.C20H17N3.C20H20N2O.C14H12N4O2.C11H13N3O.CO2.CH4/c1-14-4-6-17(7-5-14)23(29)25-22-13-21(26-27-22)20-12-15(2)28(16(20)3)19-10-8-18(24)9-11-19;1-14-12-17(15(2)23(14)16-8-4-3-5-9-16)20-13-21-18-10-6-7-11-19(18)22-20;1-13-9-19(16-10-15-5-3-8-20(15)21-12-16)14(2)22(13)17-6-4-7-18(23)11-17;15-13-11(14(16)19)12(20-18-13)10-7-6-9(17-10)8-4-2-1-3-5-8;1-6-2-3-7(4-6)8-5-14-10(12)9(8)11(13)15;2-1-3;/h4-13H,1-3H3,(H2,25,26,27,29);3-13H,1-2H3;4,6-7,9-12,23H,3,5,8H2,1-2H3;1-7,17H,(H2,15,18)(H2,16,19);2-3H,4-5H2,1H3,(H2,12,14)(H2,13,15);;1H4
InChIKeyLXERUXDPPBIQSF-UHFFFAOYSA-N
MW1584.69 g/mol
LogP17.35
Rot. Bonds13

About 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane

5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane (PubChem CID 159482660) has the molecular formula C90H87BrN16O7 and a molecular weight of 1584.69 g/mol. Its IUPAC name is 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane.

Molecular Properties

Compound Name5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane
PubChem CID159482660
Molecular FormulaC90H87BrN16O7
Molecular Weight1584.69 g/mol
Exact Mass1582.61
IUPAC Name5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane
SMILESC.CC1=CC=C(C2=C(C(N)=O)C(N)=NC2)C1.Cc1cc(-c2cnc3c(c2)CCC3)c(C)n1-c1cccc(O)c1.Cc1cc(-c2cnc3ccccc3n2)c(C)n1-c1ccccc1.Cc1ccc(C(=O)Nc2cc(-c3cc(C)n(-c4ccc(Br)cc4)c3C)[nH]n2)cc1.NC(=O)c1c(N)noc1-c1ccc(-c2ccccc2)[nH]1.O=C=O
InChIInChI=1S/C23H21BrN4O.C20H17N3.C20H20N2O.C14H12N4O2.C11H13N3O.CO2.CH4/c1-14-4-6-17(7-5-14)23(29)25-22-13-21(26-27-22)20-12-15(2)28(16(20)3)19-10-8-18(24)9-11-19;1-14-12-17(15(2)23(14)16-8-4-3-5-9-16)20-13-21-18-10-6-7-11-19(18)22-20;1-13-9-19(16-10-15-5-3-8-20(15)21-12-16)14(2)22(13)17-6-4-7-18(23)11-17;15-13-11(14(16)19)12(20-18-13)10-7-6-9(17-10)8-4-2-1-3-5-8;1-6-2-3-7(4-6)8-5-14-10(12)9(8)11(13)15;2-1-3;/h4-13H,1-3H3,(H2,25,26,27,29);3-13H,1-2H3;4,6-7,9-12,23H,3,5,8H2,1-2H3;1-7,17H,(H2,15,18)(H2,16,19);2-3H,4-5H2,1H3,(H2,12,14)(H2,13,15);;1H4
InChIKeyLXERUXDPPBIQSF-UHFFFAOYSA-N
XLogP17.35
TPSA358.01 Ų
H-Bond Donors8
H-Bond Acceptors18
Rotatable Bonds13
Heavy Atoms114
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001584.69
LogP ≤ 517.35
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'pyrrole_A(118)', 'substructure': 'N/A'}

Analyze 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane?
The IUPAC name of 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane (CID 159482660) is 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane.
What is the SMILES notation for 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane?
The canonical SMILES for 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane is C.CC1=CC=C(C2=C(C(N)=O)C(N)=NC2)C1.Cc1cc(-c2cnc3c(c2)CCC3)c(C)n1-c1cccc(O)c1.Cc1cc(-c2cnc3ccccc3n2)c(C)n1-c1ccccc1.Cc1ccc(C(=O)Nc2cc(-c3cc(C)n(-c4ccc(Br)cc4)c3C)[nH]n2)cc1.NC(=O)c1c(N)noc1-c1ccc(-c2ccccc2)[nH]1.O=C=O.
What is the InChIKey of 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane?
The InChIKey is LXERUXDPPBIQSF-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H21BrN4O.C20H17N3.C20H20N2O.C14H12N4O2.C11H13N3O.CO2.CH4/c1-14-4-6-17(7-5-14)23(29)25-22-13-21(26-27-22)20-12-15(2)28(16(20)3)19-10-8-18(24)9-11-19;1-14-12-17(15(2)23(14)16-8-4-3-5-9-16)20-13-21-18-10-6-7-11-19(18)22-20;1-13-9-19(16-10-15-5-3-8-20(15)21-12-16)14(2)22(13)17-6-4-7-18(23)11-17;15-13-11(14(16)19)12(20-18-13)10-7-6-9(17-10)8-4-2-1-3-5-8;1-6-2-3-7(4-6)8-5-14-10(12)9(8)11(13)15;2-1-3;/h4-13H,1-3H3,(H2,25,26,27,29);3-13H,1-2H3;4,6-7,9-12,23H,3,5,8H2,1-2H3;1-7,17H,(H2,15,18)(H2,16,19);2-3H,4-5H2,1H3,(H2,12,14)(H2,13,15);;1H4.
What are the key properties of 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane?
5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane has a molecular weight of 1584.69 g/mol, XLogP of 17.35, 13 rotatable bonds, 8 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 5-amino-3-(4-methylcyclopenta-1,3-dien-1-yl)-2H-pyrrole-4-carboxamide;3-amino-5-(5-phenyl-1H-pyrrol-2-yl)-1,2-oxazole-4-carboxamide;N-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-1H-pyrazol-3-yl]-4-methylbenzamide;carbon dioxide;3-[3-(6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)-2,5-dimethylpyrrol-1-yl]phenol;2-(2,5-dimethyl-1-phenylpyrrol-3-yl)quinoxaline;methane is sourced from PubChem (CID 159482660), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).